2-aminoethoxydiphenyl borate

Subscribe to Selected New Research on 2-aminoethoxydiphenyl borate

10 relevant articles (0 outcomes, 1 trials/studies) found for this Bio-Agent

Description: is a novel membrane-penetrable modulator; structure in first source

Also Known As:

2-APB compound; 2APB; bis phenyl(2-aminoethoxy)borate

Bio-Agent Context: Research Results

Inorganic Chemicals: 5

Boron Compounds: 42

2-aminoethoxydiphenyl borate: 10

Organic Chemicals: 40

Boron Compounds: 42

2-aminoethoxydiphenyl borate: 10

Experts

1.	Bose, Diptiman D: 1 article (04/2005)
2.	Padar, Shanthala: 1 article (04/2005)
3.	Livesey, John C: 1 article (04/2005)
4.	Thomas, David W: 1 article (04/2005)
5.	Shigenobu, Koki: 1 article (09/2002)
6.	Okamoto, Takao: 1 article (09/2002)
7.	Tanaka, Yoshio: 1 article (09/2002)
8.	Imai, Toshiyasu: 1 article (09/2002)
9.	Tanaka, Hikaru: 1 article (09/2002)
10.	Koike, Katsuo: 1 article (09/2002)

Related Diseases

1.	Ischemia 08/07/2006 - "AIM: To study the effects of hepatic ischemia/reperfusion (I/R) injury on store-operated calcium channel (SOC) currents (I(SOC)) in freshly isolated rat Kupffer cells, and the effects of Ca(2+) channel blockers, 2-aminoethoxydiphenyl borate (2-APB), SK and F96365, econazole and miconazole, on I(SOC) in isolated rat Kupffer cells after hepatic I/R injury" Get all the results and reference details, order at left...
2.	Stomach Neoplasms (Stomach Cancer) 09/01/2003 - "Its antagonist, 2APB, may thus be useful for the specific treatment of peritoneal dissemination of gastric cancer." 09/01/2003 - "The antagonist of IP3R, 2APB, inhibited cell proliferation and induced apoptosis in gastric cancer cells from malignant ascites at concentrations of 100 nM to 100 microM in a dose-dependent manner" 09/01/2003 - "On the other hand, 2APB showed a weak effect on other gastric cancer cells established from primary tumors (SNU1), lymph node metastases or liver metastases (MKN1 or 74), methothelial cell lines Met5A and myeloid leukemia HL60 cells" Get all the results and reference details, order at left...
3.	Neoplasms (Cancer) 09/01/2003 - "On the other hand, 2APB showed a weak effect on other gastric cancer cells established from primary tumors (SNU1), lymph node metastases or liver metastases (MKN1 or 74), methothelial cell lines Met5A and myeloid leukemia HL60 cells" Get all the results and reference details, order at left...
4.	Neoplasm Metastasis (Metastasis) 09/01/2003 - "On the other hand, 2APB showed a weak effect on other gastric cancer cells established from primary tumors (SNU1), lymph node metastases or liver metastases (MKN1 or 74), methothelial cell lines Met5A and myeloid leukemia HL60 cells" Get all the results and reference details, order at left...
5.	Lung Neoplasms (Lung Cancer) 04/15/2005 - "2-Aminoethoxydiphenyl borate perturbs hormone-sensitive calcium stores and blocks store-operated calcium influx pathways independent of cytoskeletal disruption in human A549 lung cancer cells." Get all the results and reference details, order at left...
14 Diseases and 10 more articles analyzed in the Research Interface, order at left...

Related Drugs and Biologics

1.	Calcium Channels (Calcium Channel)
2.	Miconazole
3.	Econazole
4.	Calcium
5.	Large-Conductance Calcium-Activated Potassium Channels (Maxi-K Channels)
6.	Thapsigargin
7.	Uridine
8.	Type C Phospholipases
9.	Phenylephrine (Neo-Synephrine)
10.	Atrial Natriuretic Factor (ANF)
17 Drugs and Important Bio-Agents and 6 more articles analyzed in the Research Interface, order at left...

Research Interface

Rapidly retrieve summaries of all the evidence for any disease in seconds. Save hours of search and analysis time. CureHunter is unlike any "search engine" you have ever used. Where standard "search engines" produce lists of links, CureHunter quantifies evidence, extracts it from the literature and calculates a result you can use to immediately facilitate evidence based decision making in Real Clinical Time.

Unlimited Disease, Drug and Therapy Search
2 clicks from Disease to Drug to Evidence
Trial References
All the Positive Outcomes
Detailed Relationship Timeline Charts
Full Article Reference Details
Includes Mobile Interface Subscription
One-click to FDA Products/Patents
Request Institution License details >>

Price:

$490.00 access via web interface, 1 year subscription

Proceed to Checkout >>

Mobile Interface

Retrieve summaries of all the evidence for any disease from your Mobile Phone or PDA. Accelerate decision making in the field. Speed up your study of new drug and disease domains. Refresh your knowledge on the road.

Access from any web enabled PDA or Phone
Trial references
All the Positive Outcomes
Drug and Therapy searches
Full Article Reference Details
Try Mobile Interface >>

Price:

$45.00 access via "curehunter.com/m", 1 year subscription

Proceed to Checkout >>